Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-05-000017

Sr. VP Research & Development bought 9,000 shares at $6.31 ($56,790)

From the SEC's structured data for this filing

Trades in this filing

LEVY MICHAEL D · Sr. VP Research & Development

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2005-05-12 Purchase : show line 1 in the form +9,000 $6.31 $56,790 9,000 D
Open-market purchases · 9,000 sh · avg $6.31 · $56,790
Loading xslF345X02/edgar.xml…